It lowered fasting and postprandial blood sugar levels and glycosylated hemoglobin (A1c) levels — but not significantly.

First, the details.

• 40 adults with type 2 diabetes and A1c levels greater than 8.5% (less than 7% is the target) after treatment with conventional antidiabetes drugs.
• They were randomly assigned to Hyponidd 2 tablets taken 3 times a day for 3 months or a placebo.
• Patients and the researchers did not know the treatment assignment.
• Other drugs to treat diabetes or other diseases were continued.

And, the results.

• Changes in the fasting blood sugar levels and the blood sugar levels after a meal (postprandial) did not change significantly.
• A1c levels also failed to change significantly.

The bottom line?
This is the second study (according to these authors) where Hyponidd failed to make a significant change in diabetes control.

The researchers hold out hope that perhaps the failure to respond had something to do with the possibility that these patients were “resistant” to diabetes treatment.

Maybe, but in the absence of any studies with positive outcomes how can a dispassionate observer come to any conclusion other than Hyponidd is not an effective treatment for type 2 diabetes?

The ingredients in Hyponidd include Vijaysar (Pterocarpus marsupium), Gurmar (Gymneme Sylvestre), Jambu Beej (syzigium Cumine), Amla (Emblica Officianale), Haldi (Gurcuma Longa), Neem (Melia Azadirachta), Trivang Bhasma and Shilajit.

7/8/07 9:40 JR